tirzepatide shortage fda The says the Zepbound is over. That's rattling the weight loss industry FDA says tirzepatide shortage is
Description
The maximum FDA-approved Wegovy dose is now 7.2 mg weekly (as of March 2026)

Contedo revisado pela equipe farmacutica da Relifarm Medicamentos Informaes verificadas por farmacutico habilitado, conforme a legislao sanitria vigente
Due to its significant weight loss benefits, a higher-dose version was later introduced as Wegovy, specifically for weight management in individuals with obesity or overweight conditions
Trulicity is generally more affordable and still provides excellent blood sugar control and steady weight support